Better Therapeutics to seek strategic alternatives, be delisted from Nasdaq

Better Therapeutics announced today that the company is terminating its employees and will explore strategic alternatives, including assignment for the benefit of creditors and/or a wind-down of the company. This decision was made at a special meeting of the board of directors on Wednesday evening, March 13. Further, as previously disclosed, the company’s securities are subject to delisting from the Nasdaq Stock Market unless the company presents a plan to regain compliance with Nasdaq’s continued listing standards before the Nasdaq hearings panel. The company has voluntarily requested a delisting of its securities and expects its securities to be delisted in the near term.